Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph.

Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph. Abstract Text:

Philip A Bird,Evan J Begg,Mei Zhang,Allan T Keast,Daran P Murray,Thomas J Balkany,Philip A Bird,Evan J Begg,Mei Zhang,Allan T Keast,Daran P Murray,Thomas J Balkany,Philip A Bird,Evan J Begg,Mei Zhang,Allan T Keast,Daran P Murray,Thomas J Balkany,

OBJECTIVE: To compare methylprednisolone concentrations in the perilymph of the human ear and in plasma after intratympanic (IT) or intravenous (IV) administration. METHODS: Methylprednisolone concentrations in the perilymph of patients during cochlear implantation were compared after 3 dosing strategies of methylprednisolone solution for injection (40 mg/ml): 1) IT administration of up to 40 mg was injected into the middle ear through the external auditory canal via a 27-gauge needle passed through a small anterosuperior myringotomy; 2) IV administration of 1 mg/kg was given as a single injection over 30 seconds; 3) IV administration of 10 mg/kg was infused over 30 minutes. Perilymph (single sample, approximately 20 microL) was sampled using a needle passed through the round window membrane, from 0.5 to 3 hours after dosing. In most patients, simultaneous blood sampling was performed. Methylprednisolone concentrations were measured by high-performance liquid chromatography with a limit of quantification of 0.001 mg/L. RESULTS: In 39 patients studied, 33 perilymph samples were suitable for measurement, along with 26 plasma samples. Median perilymph concentrations were 6.7 mg/L (n = 18; range, 0.2-89.4 mg/L) after IT administration, 0.053 mg/L (n = 8; range, 0-0.47 mg/L) after IV injection of 1 mg/kg, and 0.2 mg/L (n = 7; range, 0.067-3.1 mg/L) after IV infusion of 10 mg/kg. The median perilymph concentrations were 126-fold higher after the IT administration than after 1 mg/kg IV (p = 0.0003) and 33-fold higher than after 10 mg/kg IV infusion (p = 0.0045). Plasma concentrations after IT administration were 16-fold lower than after IV administration of 1 mg/kg (p = 0.0006), and 136-fold lower than after IV infusion of 10 mg/kg (p = 0.0006). CONCLUSION: IT administration of methylprednisolone in humans results in much higher perilymph concentrations and much lower systemic concentrations than IV administration.

Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph. Publishing Authors By Initials

PA Bird,EJ Begg,M Zhang,AT Keast,DP Murray,TJ Balkany,PA Bird,EJ Begg,M Zhang,AT Keast,DP Murray,TJ Balkany,PA Bird,EJ Begg,M Zhang,AT Keast,DP Murray,TJ Balkany,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: Otology & neurotology : official publication of th

VOLUME: 28

Page Numbers: 1124-30

Journal Abbreviation: Otol. Neurotol.

ISSN: 1531-7129

DAY: 28

MONTH: Dec

YEAR: 2007

Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 100961504

Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph.

AFFILIATION: Department of Otolaryngology, Head and Neck Surgery, Christchurch Hospital, New Zealand. phil.bird@entdocs.co.nz

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Otol Neurotol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph Related Publications

• Benefits of bilateral cochlear implantation: a review.
• Borderline pediatric cochlear implant candidates: preoperative and postoperative results.
• Changes in stimulation levels over time in nucleus 22 cochlear implant users.
• Cochlear implantation in individuals with Usher type 1 syndrome.
• Cochlear implantation in organ transplantation.
• Comparison of language ability in children with cochlear implants placed in oral and total communication educational settings.
• Editorial.
• Giant mastoid osteoma with postoperative high-frequency sensorineural hearing loss.
• Intratympanic versus intravenous delivery of methylprednisolone to cochlear perilymph.
• Novel intracochlear electrode positioner: effects on electrode position.
• Objective methods in postlingually and prelingually deafened adults for programming cochlear implants: ESR and NRT.
• Small-fenestra cochleostomy for MED-EL electrode.
• Using electrically evoked auditory reflex thresholds to fit the CLARION cochlear implant.